S.4535: FDASRA Act of 2022

About This Bill

Bill Version

Bill Summary

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022 This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

(Source: Library of Congress)

Bill Actions

Date Description
July 14, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
July 14, 2022

Introduced in the Senate by Richard M. Burr (R-N.C.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page